Monday, June 27, 2016

AstraZeneca Pushes to Protect Crestor From Generic Competition by ANDREW POLLACK


By ANDREW POLLACK

The drug maker is trying to get its popular anticholesterol pill approved to treat children who have a rare disease characterized by high cholesterol.

Published: June 28, 2016 at 12:00AM

from NYT Business Day http://ift.tt/2902XPL



from WordPress http://ift.tt/2905Foa
via Hadi Aboukhater

No comments:

Post a Comment